Rituximab for follicular lymphoma: watch and wait, watch and worry, or watch and live?

被引：6
|
作者：
LeBlanc, Thomas [1 ]
Kamal, Arif [2 ]
Abernethy, Amy [2 ]
机构：
[1] Duke Univ, Sch Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA
[2] Duke Univ, Ctr Learning Hlth Care, Duke Clin Res Inst, Sch Med, Durham, NC 27710 USA
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 07期
关键词：
QUALITY-OF-LIFE;
D O I：
10.1016/S1470-2045(14)70215-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E251 / E252
页数：3
相关论文
共 50 条
  • [1] Follicular lymphoma: watch and wait is watch and worry
    Ansell, Stephen M.
    LANCET ONCOLOGY, 2014, 15 (04): : 368 - 369
  • [2] 'Watch and wait' or 'watch and worry'?
    Nature Reviews Clinical Oncology, 2014, 11 (5) : 240 - 240
  • [3] Is there a role for "watch and wait" in follicular lymphoma in the rituximab era?
    Kahl, Brad
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, : 433 - 438
  • [4] The role of "watch and wait'' in intestinal follicular lymphoma in rituximab era
    Tari, Akira
    Asaoku, Hideki
    Takata, Katsuyoshi
    Fujimori, Shunji
    Tanaka, Shinji
    Fujihara, Megumu
    Koga, Tadashi
    Yoshino, Tadashi
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (03) : 321 - 328
  • [5] Watch and wait in follicular lymphoma: time for change?
    Hiddemann, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (42) : 2181 - 2182
  • [6] Advanced Stage Follicular Lymphoma - Watch and Wait or Immunochemotherapy?
    Pereira, Dulcineia
    Teixeira, Carolina
    Ramalheira, Sofia
    Rocha, Patricia
    Moreira, Claudia
    Rosinha, Alina
    Domingues, Duarte
    Amaral, Natasha
    Mesquita, Edgar
    Brito, A.
    Viterbo, Luisa
    Oliveira, Isabel
    Domingues, Nelson
    Moreira, Ilidia
    Espirito-Santo, Ana
    Chacim, Sergio
    Leite, Luis
    Ferreira, Isabel Cristina
    Henrique, Rui
    Martins, Angelo
    Mariz, Jose Mario
    BLOOD, 2014, 124 (21)
  • [7] Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era
    Sayako Yuda
    Dai Maruyama
    Akiko Miyagi Maeshima
    Shinichi Makita
    Hideaki Kitahara
    Ken-ichi Miyamoto
    Suguru Fukuhara
    Wataru Munakata
    Tatsuya Suzuki
    Yukio Kobayashi
    Kinuko Tajima
    Hirokazu Taniguchi
    Kensei Tobinai
    Annals of Hematology, 2016, 95 : 2017 - 2022
  • [8] Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era
    Yuda, Sayako
    Maruyama, Dai
    Maeshima, Akiko Miyagi
    Makita, Shinichi
    Kitahara, Hideaki
    Miyamoto, Ken-ichi
    Fukuhara, Suguru
    Munakata, Wataru
    Suzuki, Tatsuya
    Kobayashi, Yukio
    Tajima, Kinuko
    Taniguchi, Hirokazu
    Tobinai, Kensei
    ANNALS OF HEMATOLOGY, 2016, 95 (12) : 2017 - 2022
  • [9] Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era
    Yuda, Sayako
    Maruyama, Dai
    Maeshima, Akiko Miyagi
    Makita, Shin-ichi
    Kitahara, Hideaki
    Ken-ichi, Miyamoto
    Fukuhara, Suguru
    Munakata, Wataru
    Suzuki, Tatsuya
    Kobayashi, Yukio
    Tajima, Kinuko
    Taniguchi, Hirokazu
    Tobinai, Kensei
    BLOOD, 2014, 124 (21)
  • [10] Indolent Lymphoma: Can Rituximab Resolve the Watch-and-Wait Debate?
    Ross, Emma
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (04) : 220 - 221
12345